Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.
- Journal
- PubMed
In The Last Decade
doi.org/w68752365 →Countries where authors are citing Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.
This map shows the geographic impact of Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. more than expected).
Fields of papers citing Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.
This network shows the impact of Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma..
About Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.
This paper, published in 2002, received 619 indexed citations . Written by Gavin J. Gordon, Roderick V. Jensen, Li Li Hsiao, Steven R. Gullans, Joshua Blumenstock, Sridhar Ramaswamy, William G. Richards, David J. Sugarbaker and Raphael Bueno covering the research area of Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. It is primarily cited by scholars working on Molecular Biology (461 citations), Artificial Intelligence (226 citations) and Computer Vision and Pattern Recognition (128 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w68752365.